Beta-Amyloid Bri (1-34) – 1 mg

Overview

Beta-Amyloid Bri (1-34) is a highly relevant peptide for researchers studying familial British dementia (FBD) and Alzheimer’s Disease. This peptide, derived from the mutated BRI2 gene, plays a significant role in the formation of amyloid plaques, characteristic features observed in the brains of affected patients. Understanding the properties and behaviors of Beta-Amyloid peptides can provide insights into the mechanisms underlying neurodegenerative diseases.

Key Features

• High-quality Beta-Amyloid Bri (1-34) peptide for reliable research
• Critical for studies related to familial British dementia and Alzheimer’s Disease
• Significant in understanding amyloid plaque formation in the brain
• Research-grade purity ensures accurate experimental results
• Also offers compatibility with other related products like our PKG Substrate and Autocamtide-2

Specifications

FAQ

What is Beta-Amyloid Bri (1-34) used for?

This peptide is primarily utilized in research to study its role in neurodegenerative diseases, particularly familial British dementia and Alzheimer’s Disease.

How is this peptide delivered?

Beta-Amyloid Bri (1-34) is supplied in a lyophilized form, allowing for easy reconstitution and use in various assays.

Are there similar peptides available?

Yes, we also offer related products such as CREBtide 5-FAM labeled and various other peptides for your research needs.

If you’re looking to enhance your studies on amyloid-related pathologies, consider adding Beta-Amyloid Bri (1-34) to your laboratory. This peptide is essential for unlocking new research avenues in understanding the neurodegenerative processes associated with FBD and Alzheimer’s Disease.